Search

Author/Creator Beringer, Paul M.

1. Cover Feature: Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity (Chem. Eur. J. 49/2021). Issue 49 (12th August 2021)

Authors:
Ganesan, Rajasekaran; Dughbaj, Mansour A.; Ramirez, Lisa; Beringer, Steven; Aboye, Teshome L.; Shekhtman, Alexander; Beringer, Paul M.; Camarero, Julio A.
Journal:
Chemistry
Issue:
Volume 27:Issue 49(2021)
Page Start:
12450
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Physiologically‐Based Pharmacokinetic‐Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor‐Tezacaftor‐Ivacaftor With Nirmatrelvir‐Ritonavir for the Treatment of COVID‐19. Issue 6 (6th April 2022)

Authors:
Hong, Eunjin; Almond, Lisa M.; Chung, Peter S.; Rao, Adupa P.; Beringer, Paul M.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 111:Issue 6(2022)
Page Start:
1324
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series. Issue 4 (12th March 2023)

Authors:
Hong, Eunjin; Li, Regina; Shi, Alan; Almond, Lisa M.; Wang, Joshua; Khudari, Amin Z.; Haddad, Soumar; Sislyan, Sarkis; Angelich, Marissa; Chung, Peter S.; Rao, Adupa P.; Beringer, Paul M.
Journal:
Pharmacotherapy
Issue:
Volume 43:Issue 4(2023)
Page Start:
291
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗